Grown Rogue International Inc. (CSE:GRIN)
0.5400
-0.0200 (-3.57%)
At close: Feb 9, 2026
Grown Rogue International Revenue
Grown Rogue International had revenue of $5.36M USD in the quarter ending September 30, 2025, a decrease of -23.30%. This brings the company's revenue in the last twelve months to $22.15M, up 1.48% year-over-year. In the year 2024, Grown Rogue International had annual revenue of $27.02M with 23.77% growth.
Revenue (ttm)
$22.15M
Revenue Growth
+1.48%
P/S Ratio
4.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
134.97M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.02M | 5.19M | 23.77% |
| Dec 31, 2023 | 21.83M | -1.52M | -6.53% |
| Oct 31, 2023 | 23.35M | 5.60M | 31.51% |
| Oct 31, 2022 | 17.76M | 8.38M | 89.34% |
| Oct 31, 2021 | 9.38M | 5.14M | 121.22% |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ascend Wellness Holdings | 718.79M |
| Planet 13 Holdings | 151.05M |
| Auxly Cannabis Group | 146.00M |
| Medexus Pharmaceuticals | 145.00M |
| Cannara Biotech | 112.25M |
| HLS Therapeutics | 77.79M |
| Charlotte's Web Holdings | 68.58M |
| Vext Science | 66.63M |